Dewetting: From Physics to the Biology of Intoxicated Cells
Pathogenic micro organism colonize or disseminate into cells and tissues by inducing large-scale remodeling of host membranes. The bodily phenomena underpinning these big membrane extension and deformation are poorly understood. Invasive strategies of pathogens have been simply recently enriched by the define of a spectacular mode of opening of huge transendothelial cell macroaperture (TEM) tunnels correlated to the dissemination of EDIN-producing strains of Staphylococcus aureus by means of a hematogenous route or to the induction of gelatinous edema triggered by the edema toxin from Bacillus anthracis.
Remarkably, these extraordinarily dynamic tunnels shut shortly after they attain a maximal measurement. Opening and closure of TEMs in cells lasts for hours with out inducing endothelial cell demise. Multidisciplinary analysis have started to produce a broader perspective of every the molecular determinants controlling cytoskeleton group at newly curved membranes generated by the opening of TEMs and the bodily processes controlling the dynamics of these tunnels.
Proper right here we speak in regards to the analogy between the opening of TEM tunnels and the bodily concepts of dewetting, stemming from a parallel between membrane stress and ground stress. This analogy provides a broad framework to analysis biophysical constraints in cell membrane dynamics and their diversion by positive invasive microbial brokers
Present advances in myeloid-derived suppressor cell biology
In latest occasions, discovering out the place of myeloid-derived suppressor cells (MDSCs) in numerous pathological inflammatory conditions has become a very energetic evaluation area. Although the place of MDSCs in most cancers is relatively successfully established, their place in non-cancerous pathological conditions stays in its infancy resulting in rather a lot confusion. Our targets on this overview are to cope with some present advances in MDSC evaluation in order to lower such confusion and to produce an notion into their function inside the context of various illnesses.
The following issues is perhaps significantly centered upon:
(1) definition and characterization of MDSCs;
(2) whether or not or not all MDSC populations embrace immature cells;
(3) technical factors in MDSC isolation, estimation and characterization;
(4) the origin of MDSCs and their anatomical distribution in effectively being and sickness;
(5) mediators of MDSC development and accumulation;
(6) parts that determine the expansion of 1 MDSC inhabitants over the other;
(7) the Yin and Yang roles of MDSCs. Moreover, the capabilities of MDSCs is perhaps addressed all by the textual content material.

TK Blocking Peptide |
|||
AF7678-BP | Affbiotech | 1mg | EUR 234 |
Rb Blocking Peptide |
|||
AF7698-BP | Affbiotech | 1mg | EUR 234 |
T Blocking Peptide |
|||
BF0015-BP | Affbiotech | 1mg | EUR 234 |
A1 Blocking Peptide |
|||
3401BP-50 | Biovision | each | EUR 183.6 |
Ub Blocking Peptide |
|||
20-abx063395 | Abbexa |
|
|
E7 Blocking Peptide |
|||
BF0311-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
BF0418-BP | Affbiotech | 1mg | EUR 234 |
PR Blocking Peptide |
|||
BF0581-BP | Affbiotech | 1mg | EUR 234 |
RB Blocking Peptide |
|||
BF0614-BP | Affbiotech | 1mg | EUR 234 |
ER Blocking Peptide |
|||
BF0674-BP | Affbiotech | 1mg | EUR 234 |
GK Blocking Peptide |
|||
AF0829-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
AF5004-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
AF6066-BP | Affbiotech | 1mg | EUR 234 |
GR Blocking Peptide |
|||
AF6067-BP | Affbiotech | 1mg | EUR 234 |
TK Blocking Peptide |
|||
AF6068-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
AF6098-BP | Affbiotech | 1mg | EUR 234 |
IR Blocking Peptide |
|||
AF6099-BP | Affbiotech | 1mg | EUR 234 |
F7 Blocking Peptide |
|||
33R-1026 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DLG4 antibody, catalog no. 70R-4080 |
GC Blocking Peptide |
|||
33R-10350 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GC antibody, catalog no. 70R-10252 |
A1 Blocking Peptide |
|||
33R-10744 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of A1 antibody, catalog no. 70R-11802 |
KC Blocking Peptide |
|||
33R-11041 | Fitzgerald | 50 ug | EUR 229.2 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KC antibody, catalog no. 70R-12298 |
F2 Blocking Peptide |
|||
33R-1783 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F2 antibody, catalog no. 70R-8514 |
PB Blocking Peptide |
|||
33R-2067 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192 |
AC Blocking Peptide |
|||
33R-3003 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ac antibody, catalog no. 70R-1978 |
XK Blocking Peptide |
|||
33R-7655 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XK antibody, catalog no. 70R-7274 |
F7 Blocking Peptide |
|||
33R-7835 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F7 antibody, catalog no. 70R-9970 |
PC Blocking Peptide |
|||
33R-8614 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PC antibody, catalog no. 70R-9828 |
TH Blocking Peptide |
|||
33R-3167 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TH antibody, catalog no. 70R-7854 |
F8 Blocking Peptide |
|||
33R-3569 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of F8 antibody, catalog no. 70R-9971 |
NP Blocking Peptide |
|||
33R-3631 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NP antibody, catalog no. 70R-2286 |
GC Blocking Peptide |
|||
33R-4418 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GC antibody, catalog no. 70R-10253 |
XK Blocking Peptide |
|||
33R-5017 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of XK antibody, catalog no. 70R-7169 |
SI Blocking Peptide |
|||
33R-5258 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SI antibody, catalog no. 70R-7230 |
GK Blocking Peptide |
|||
33R-5595 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GK antibody, catalog no. 70R-4533 |
TH Blocking Peptide |
|||
33R-6309 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TH antibody, catalog no. 70R-10442 |
HB Blocking Peptide |
|||
33R-6336 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of hb antibody, catalog no. 70R-3198 |
N Blocking Peptide |
|||
33R-6561 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LSM8 antibody, catalog no. 70R-4590 |
SI Blocking Peptide |
|||
33R-6891 | Fitzgerald | 100 ug | EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SI antibody, catalog no. 70R-7205 |
KC Blocking Peptide |
|||
5212BP-50 | Biovision | each | EUR 183.6 |
OR Blocking Peptide |
|||
DF10250-BP | Affbiotech | 1mg | EUR 234 |
CP Blocking Peptide |
|||
DF9369-BP | Affbiotech | 1mg | EUR 234 |
C7 Blocking Peptide |
|||
DF9410-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
DF7358-BP | Affbiotech | 1mg | EUR 234 |
FH Blocking Peptide |
|||
DF7460-BP | Affbiotech | 1mg | EUR 234 |
AR Blocking Peptide |
|||
DF6783-BP | Affbiotech | 1mg | EUR 234 |
C5 Blocking Peptide |
|||
DF7719-BP | Affbiotech | 1mg | EUR 234 |
GC Blocking Peptide |
|||
DF7840-BP | Affbiotech | 1mg | EUR 234 |
TG Blocking Peptide |
|||
DF7885-BP | Affbiotech | 1mg | EUR 234 |
F5 Blocking Peptide |
|||
DF8265-BP | Affbiotech | 1mg | EUR 234 |
Ob Blocking Peptide |
|||
DF8583-BP | Affbiotech | 1mg | EUR 234 |
ST Blocking Peptide |
|||
DF8616-BP | Affbiotech | 1mg | EUR 234 |
C6 Blocking Peptide |
|||
DF3963-BP | Affbiotech | 1mg | EUR 234 |
C9 Blocking Peptide |
|||
DF3964-BP | Affbiotech | 1mg | EUR 234 |
MB Blocking Peptide |
|||
DF4194-BP | Affbiotech | 1mg | EUR 234 |
NT Blocking Peptide |
|||
DF4245-BP | Affbiotech | 1mg | EUR 234 |
PC Blocking Peptide |
|||
DF4364-BP | Affbiotech | 1mg | EUR 234 |
F3 Blocking Peptide |
|||
DF6400-BP | Affbiotech | 1mg | EUR 234 |
HP Blocking Peptide |
|||
DF6467-BP | Affbiotech | 1mg | EUR 234 |
F9 Blocking Peptide |
|||
DF6474-BP | Affbiotech | 1mg | EUR 234 |
GK Blocking Peptide |
|||
DF3151-BP | Affbiotech | 1mg | EUR 234 |
FX Blocking Peptide |
|||
20-abx161511 | Abbexa |
|
|
GW Blocking Peptide |
|||
20-abx162574 | Abbexa |
|
|
PEPT1 Blocking Peptide |
|||
20-abx063272 | Abbexa |
|
|
C-Peptide Blocking Peptide |
|||
3277BP-50 | Biovision | each | EUR 183.6 |
SKI Blocking Peptide |
|||
AF7536-BP | Affbiotech | 1mg | EUR 234 |
EED Blocking Peptide |
|||
AF7558-BP | Affbiotech | 1mg | EUR 234 |
TXN Blocking Peptide |
|||
AF7577-BP | Affbiotech | 1mg | EUR 234 |
Bim Blocking Peptide |
|||
AF7620-BP | Affbiotech | 1mg | EUR 234 |
Bim Blocking Peptide |
|||
AF7621-BP | Affbiotech | 1mg | EUR 234 |
LAT Blocking Peptide |
|||
AF7625-BP | Affbiotech | 1mg | EUR 234 |
LAT Blocking Peptide |
|||
AF7626-BP | Affbiotech | 1mg | EUR 234 |
DR6 Blocking Peptide |
|||
AF7652-BP | Affbiotech | 1mg | EUR 234 |
PZR Blocking Peptide |
|||
AF7665-BP | Affbiotech | 1mg | EUR 234 |
PZR Blocking Peptide |
|||
AF7666-BP | Affbiotech | 1mg | EUR 234 |
PZR Blocking Peptide |
|||
AF7667-BP | Affbiotech | 1mg | EUR 234 |
Myc Blocking Peptide |
|||
AF7674-BP | Affbiotech | 1mg | EUR 234 |
p53 Blocking Peptide |
|||
AF7685-BP | Affbiotech | 1mg | EUR 234 |
p53 Blocking Peptide |
|||
AF7686-BP | Affbiotech | 1mg | EUR 234 |
APP Blocking Peptide |
|||
AF7687-BP | Affbiotech | 1mg | EUR 234 |
Lck Blocking Peptide |
|||
AF7694-BP | Affbiotech | 1mg | EUR 234 |
Lck Blocking Peptide |
|||
AF7695-BP | Affbiotech | 1mg | EUR 234 |
LCK Blocking Peptide |
|||
AF7696-BP | Affbiotech | 1mg | EUR 234 |
Fyn Blocking Peptide |
|||
AF7697-BP | Affbiotech | 1mg | EUR 234 |
NPM Blocking Peptide |
|||
AF7703-BP | Affbiotech | 1mg | EUR 234 |
Lyn Blocking Peptide |
|||
AF7708-BP | Affbiotech | 1mg | EUR 234 |
HCK Blocking Peptide |
|||
AF7711-BP | Affbiotech | 1mg | EUR 234 |
Bcr Blocking Peptide |
|||
AF7715-BP | Affbiotech | 1mg | EUR 234 |
Bcr Blocking Peptide |
|||
AF7716-BP | Affbiotech | 1mg | EUR 234 |
HS1 Blocking Peptide |
|||
AF7726-BP | Affbiotech | 1mg | EUR 234 |
FER Blocking Peptide |
|||
AF7737-BP | Affbiotech | 1mg | EUR 234 |
UBF Blocking Peptide |
|||
AF7743-BP | Affbiotech | 1mg | EUR 234 |
MAK Blocking Peptide |
|||
AF7757-BP | Affbiotech | 1mg | EUR 234 |
CBL Blocking Peptide |
|||
AF7763-BP | Affbiotech | 1mg | EUR 234 |
AXL Blocking Peptide |
|||
AF7793-BP | Affbiotech | 1mg | EUR 234 |
YB1 Blocking Peptide |
|||
AF7832-BP | Affbiotech | 1mg | EUR 234 |
YB1 Blocking Peptide |
|||
AF7833-BP | Affbiotech | 1mg | EUR 234 |
BTK Blocking Peptide |
|||
AF7854-BP | Affbiotech | 1mg | EUR 234 |
BTK Blocking Peptide |
|||
AF7855-BP | Affbiotech | 1mg | EUR 234 |
SF1 Blocking Peptide |
|||
AF7895-BP | Affbiotech | 1mg | EUR 234 |
Bad Blocking Peptide |
|||
AF7927-BP | Affbiotech | 1mg | EUR 234 |
AT2 Blocking Peptide |
|||
30R-AA024 | Fitzgerald | 100 ug | EUR 289.2 |
Description: A synthetic AT2 Blocking peptide for use as a blocking control in assays to test for specificity of AT2 antibody, catalog no. 70R-AR006 |
PKA Blocking Peptide |
|||
3115BP-50 | Biovision | each | EUR 183.6 |
Bax Blocking Peptide |
|||
3032BP-50 | Biovision | each | EUR 183.6 |
p53 Blocking Peptide |
|||
3036RBP-50 | Biovision | each | EUR 183.6 |
PBR Blocking Peptide |
|||
3044BP-50 | Biovision | each | EUR 183.6 |
DR4 Blocking Peptide |
|||
3061BP-50 | Biovision | each | EUR 183.6 |
DR5 Blocking Peptide |
|||
3062BP-50 | Biovision | each | EUR 183.6 |
PPY Blocking Peptide |
|||
BF0012-BP | Affbiotech | 1mg | EUR 234 |
ILK Blocking Peptide |
|||
BF0030-BP | Affbiotech | 1mg | EUR 234 |
CD5 Blocking Peptide |
|||
BF0031-BP | Affbiotech | 1mg | EUR 234 |
SRY Blocking Peptide |
|||
BF0037-BP | Affbiotech | 1mg | EUR 234 |
SST Blocking Peptide |
|||
BF0042-BP | Affbiotech | 1mg | EUR 234 |
CD6 Blocking Peptide |
|||
BF0044-BP | Affbiotech | 1mg | EUR 234 |
EGF Blocking Peptide |
|||
BF0066-BP | Affbiotech | 1mg | EUR 234 |
KDR Blocking Peptide |
|||
BF0068-BP | Affbiotech | 1mg | EUR 234 |
AGT Blocking Peptide |
|||
BF0069-BP | Affbiotech | 1mg | EUR 234 |
SYK Blocking Peptide |
|||
BF0074-BP | Affbiotech | 1mg | EUR 234 |
FER Blocking Peptide |
|||
BF0076-BP | Affbiotech | 1mg | EUR 234 |
LAL Blocking Peptide |
|||
BF0079-BP | Affbiotech | 1mg | EUR 234 |
DCX Blocking Peptide |
|||
BF0083-BP | Affbiotech | 1mg | EUR 234 |
CRK Blocking Peptide |
|||
BF0088-BP | Affbiotech | 1mg | EUR 234 |
CEA Blocking Peptide |
|||
BF0092-BP | Affbiotech | 1mg | EUR 234 |
TEC Blocking Peptide |
|||
BF0100-BP | Affbiotech | 1mg | EUR 234 |
MRGPRX2 indicators its significance in cutaneous mast cell biology: Does MRGPRX2 be part of mast cells and atopic dermatitis?
The invention of MRGPRX2 marks a necessary change in MC biology, explaining non-IgE-mediated scientific phenomena relying on MCs. As receptor for quite a few remedy, MRGPRX2 is important to drug-induced hypersensitivity.
Nonetheless, not solely remedy, however moreover endogenous mediators like neuropeptides and host safety peptides activate MRGPRX2, suggesting its broad affect in cutaneous pathophysiology.
Proper right here, we give a brief overview of MRGPRX2 and its regulation by microenvironmental stimuli, which assist MCs and shall be altered in pores and pores and skin points, and briefly contact on the purposeful packages elicited by MRGPRX2 ligation. Analysis in Mrgprb2-deficient mice (the murine ortholog) help illuminate MRGPRX2’s function in effectively being and sickness.
Present advances on this model assist the long-suspected operational unit between MCs and nerves, with MRGPRX2 being an vital component. Based on the restricted proof for a big contribution of FcεRI/IgE-activated MCs to atopic dermatitis (AD), we develop the hypothesis that MRGPRX2 constitutes the missing hyperlink connecting MCs and AD, a minimum of in chosen endotypes.
Help comes from the multifold changes inside the MC-neuronal system of AD pores and pores and skin (e.g. bigger density of MCs and nearer connections between MCs and nerves, elevated PAR-2/Substance P).
We theorize that these deregulations suffice to impress AD, nonetheless exterior triggers, numerous which activating MRGPRX2 themselves (e.g. Staphylococcus aureus) extra feed into the loop. Itch, most likely probably the most burdensome hallmark of AD, is usually non-histaminergic nonetheless tryptase-dependent, and tryptase is preferentially launched upon MRGPRX2 activation. On account of MRGPRX2 is a very energetic evaluation space, a couple of of the current gaps are susceptible to be closed shortly.
Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Preliminary Part
By binding to actin filaments, non-muscle myosin II (NMII) generates actomyosin networks that preserve distinctive contractile properties. Their dynamic nature is vital for neuronal biology along with the establishment of polarity, progress cone formation and motility, axon progress all through enchancment (and axon regeneration inside the grownup), radial and longitudinal axonal stress, and synapse formation and efficiency.
On this overview, we speak in regards to the current information on the spatial distribution and efficiency of the actomyosin cytoskeleton in quite a few axonal compartments.
We highlight a couple of of the plain contradictions and open questions inside the space, along with the place of NMII inside the regulation of axon progress and regeneration, the possibility that NMII structural affiliation alongside the axon shaft would possibly administration every radial and longitudinal contractility, and the mechanism and purposeful goal underlying NMII enrichment inside the axon preliminary part.
With the advances in reside cell imaging and super choice microscopy, it is anticipated that inside the near future the spatial distribution of NMII inside the axon, and the mechanisms by which it participates in axonal biology is perhaps extra untangled.
4-Bromobenzoic acid |
|||
20-abx183544 | Abbexa |
|
|
4-Bromobutyric acid |
|||
20-abx183545 | Abbexa |
|
|
6-Bromocaproic acid |
|||
abx183782-100g | Abbexa | 100 g | EUR 326.4 |
3-Bromopyruvic acid |
|||
20-abx180424 | Abbexa |
|
|
3-Bromopyruvic acid |
|||
B7922-1000 | ApexBio | 1 g | EUR 129.6 |
3-Bromopyruvic acid |
|||
B7922-10000 | ApexBio | 10 g | EUR 170.4 |
3-Bromopyruvic acid |
|||
B7922-25000 | ApexBio | 25 g | EUR 282 |
3-Bromopyruvic acid |
|||
B7922-5000 | ApexBio | 5 g | EUR 142.8 |
3-Bromopyruvic acid |
|||
HY-19992 | MedChemExpress | 500mg | EUR 129.6 |
3-Bromopyruvic acid |
|||
GK0949-1 | Glentham Life Sciences | 1 | EUR 86.5 |
3-Bromopyruvic acid |
|||
GK0949-5 | Glentham Life Sciences | 5 | EUR 133.6 |
Bromodichloroacetic acid |
|||
S-536 | Scientific Laboratory Supplies | 1ML | EUR 157.2 |
5-Bromo-2-furoic acid |
|||
20-abx183686 | Abbexa |
|
|
3-Bromopropionic Acid |
|||
abx188361-25g | Abbexa | 25 g | EUR 226.8 |
5-Bromonicotinic Acid |
|||
abx188524-1000g | Abbexa | 1000 g | EUR 510 |
5-Bromosalicylic Acid |
|||
abx188526-kg | Abbexa | kg | EUR 661.2 |
6-Bromonicotinic acid |
|||
GX2922-10G | Glentham Life Sciences | 10 g | EUR 170.4 |
6-Bromonicotinic acid |
|||
GX2922-25G | Glentham Life Sciences | 25 g | EUR 284.4 |
6-Bromonicotinic acid |
|||
GX2922-5G | Glentham Life Sciences | 5 g | EUR 112.8 |
2-Bromopropionic acid |
|||
S-572 | Scientific Laboratory Supplies | 1ML | EUR 84 |
6-Bromonicotinic acid |
|||
GX2922-10 | Glentham Life Sciences | 10 | EUR 110.7 |
6-Bromonicotinic acid |
|||
GX2922-25 | Glentham Life Sciences | 25 | EUR 205.7 |
6-Bromonicotinic acid |
|||
GX2922-5 | Glentham Life Sciences | 5 | EUR 63.3 |
5-Bromonicotinic acid |
|||
GK6698-10 | Glentham Life Sciences | 10 | EUR 109.5 |
5-Bromonicotinic acid |
|||
GK6698-50 | Glentham Life Sciences | 50 | EUR 327 |
11-Bromoundecanoic acid |
|||
abx182859-5g | Abbexa | 5 g | EUR 794.4 |
6-Bromo Nicotinic Acid |
|||
20-abx185306 | Abbexa |
|
|
5-Bromo-2-naphthoic acid |
|||
20-abx183693 | Abbexa |
|
|
3-Bromoisonicotinic acid |
|||
abx181922-25g | Abbexa | 25 g | EUR 276 |
3-Bromophenylacetic Acid |
|||
abx188359-500g | Abbexa | 500 g | EUR 577.2 |
2-Bromo Isobutyric Acid |
|||
20-abx187849 | Abbexa |
|
|
4-Bromophenylboronic acid |
|||
TBW00045 | ChemNorm | 5X1g | EUR 294 |
2‐BROMO‐ISO‐BUTYRIC ACID |
|||
902012 | Survival Technologies | each | Ask for price |
(R)-(+)-2-Bromopropionic Acid |
|||
20-abx182754 | Abbexa |
|
|
Bromothymol blue free acid |
|||
BB0043 | Bio Basic | 5g | EUR 69.4 |
3-Bromobenzeneboronic Acid |
|||
20-abx181919 | Abbexa |
|
|
4-Bromobenzeneboronic Acid |
|||
20-abx181163 | Abbexa |
|
|
2-Bromobenzeneboronic Acid |
|||
20-abx181735 | Abbexa |
|
|
2-Bromo-3-nitrobenzoic acid |
|||
20-abx183098 | Abbexa |
|
|
4-Bromo-2-nitrobenzoic acid |
|||
20-abx184601 | Abbexa |
|
|
Bromocresol green, free acid |
|||
BD0159 | Bio Basic | 5g | EUR 76.7 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-10G | Glentham Life Sciences | 10 g | EUR 69.6 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-25G | Glentham Life Sciences | 25 g | EUR 98.4 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-5G | Glentham Life Sciences | 5 g | EUR 60 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-10 | Glentham Life Sciences | 10 | EUR 35.5 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-25 | Glentham Life Sciences | 25 | EUR 71.1 |
4-(Bromomethyl)benzoic acid |
|||
GX5018-5 | Glentham Life Sciences | 5 | EUR 21.4 |
2-Bromo-4-chlorobenzoic acid |
|||
20-abx183100 | Abbexa |
|
|
2-Bromo-6-chlorobenzoic acid |
|||
20-abx183119 | Abbexa |
|
|
2-Bromo-6-fluorobenzoic acid |
|||
abx183121-100g | Abbexa | 100 g | EUR 794.4 |
3-Bromo-2-methylbenzoic acid |
|||
20-abx183351 | Abbexa |
|
|
2-Bromo-4-methylbenzoic acid |
|||
20-abx185725 | Abbexa |
|
|
3-Bromo-5-fluorobenzoic acid |
|||
20-abx185768 | Abbexa |
|
|
Bromocresol purple, free acid |
|||
BB0244 | Bio Basic | 25g | EUR 89.23 |
4-Bromo-2,6-difluorobenzoic acid |
|||
20-abx183530 | Abbexa |
|
|
4-Bromo-3-methoxybenzoic acid |
|||
abx183541-250g | Abbexa | 250 g | EUR 1028.4 |
3-Bromo-5-hydroxybenzoic acid |
|||
20-abx185122 | Abbexa |
|
|
4-Bromo-3-Hydroxybenzoic Acid |
|||
20-abx180512 | Abbexa |
|
|
2-Bromo-5-methoxybenzoic acid |
|||
GK5453-5 | Glentham Life Sciences | 5 | EUR 22.8 |
5-Bromo-6-Chloronicotinic Acid |
|||
20-abx182200 | Abbexa |
|
|
3-Bromo-2,4,5-Trifluorobenzoic Acid |
|||
abx188353-100g | Abbexa | 100 g | EUR 1296 |
2-Bromo-3-phenylpropionic acid |
|||
20-abx181028 | Abbexa |
|
|
Bromoxynil Octanoic acid ester |
|||
S-577 | Scientific Laboratory Supplies | 1ML | EUR 117.6 |
5-Bromo-2- pyridinecarboxylic Acid |
|||
20-abx183671 | Abbexa |
|
|
5‐BROMO‐2‐CHLOROBENZOIC ACID |
|||
602010 | Survival Technologies | each | Ask for price |
3-Bromomethylphenylboronic Acid |
|||
20-abx180423 | Abbexa |
|
|
3-bromo-5-phenyl Salicylic Acid |
|||
C4516-1 | ApexBio | 1 mg | EUR 145.2 |
Description: Ki: 140 nM for AKR1C1; 1.97 ?M for AKR1C2; 21 ?M for AKR1C3 3-bromo-5-phenyl Salicylic acid is an AKR1C1 inhibitor. |
3-bromo-5-phenyl Salicylic Acid |
|||
C4516-10 | ApexBio | 10 mg | EUR 741.6 |
Description: Ki: 140 nM for AKR1C1; 1.97 ?M for AKR1C2; 21 ?M for AKR1C3 3-bromo-5-phenyl Salicylic acid is an AKR1C1 inhibitor. |
3-bromo-5-phenyl Salicylic Acid |
|||
C4516-25 | ApexBio | 25 mg | EUR 1550.4 |
Description: Ki: 140 nM for AKR1C1; 1.97 ?M for AKR1C2; 21 ?M for AKR1C3 3-bromo-5-phenyl Salicylic acid is an AKR1C1 inhibitor. |
3-bromo-5-phenyl Salicylic Acid |
|||
C4516-5 | ApexBio | 5 mg | EUR 444 |
Description: Ki: 140 nM for AKR1C1; 1.97 ?M for AKR1C2; 21 ?M for AKR1C3 3-bromo-5-phenyl Salicylic acid is an AKR1C1 inhibitor. |
5-bromo-3-phenyl Salicylic Acid |
|||
C4610-1 | ApexBio | 1 mg | EUR 130.8 |
5-bromo-3-phenyl Salicylic Acid |
|||
C4610-10 | ApexBio | 10 mg | EUR 633.6 |
5-bromo-3-phenyl Salicylic Acid |
|||
C4610-25 | ApexBio | 25 mg | EUR 1317.6 |
5-bromo-3-phenyl Salicylic Acid |
|||
C4610-5 | ApexBio | 5 mg | EUR 382.8 |
5-Bromo-2-pyrazinecarboxylic acid |
|||
20-abx182193 | Abbexa |
|
|
6-Bromo-2-pyridinecarboxylic acid |
|||
20-abx181218 | Abbexa |
|
|
5-Bromo-2-chloroisonicotinic acid |
|||
20-abx185258 | Abbexa |
|
|
4-Bromo-2-thiophenecarboxylic acid |
|||
20-abx183539 | Abbexa |
|
|
4-Bromo-2-methylphenylboronic acid |
|||
20-abx185646 | Abbexa |
|
|
5-Bromo-2-chlorophenylboronic acid |
|||
20-abx186334 | Abbexa |
|
|
2-Bromo-4-methyl-nicotinic acid |
|||
abx186208-1g | Abbexa | 1 g | EUR 710.4 |
4-(4-Bromophenyl)butanoic acid |
|||
20-abx183462 | Abbexa |
|
|
2-Bromo-5,6-Difluorophenylboronic Acid |
|||
20-abx183108 | Abbexa |
|
|
3-Bromo-5-Methoxyphenylboronic Acid |
|||
20-abx183364 | Abbexa |
|
|
4-Bromo-2,5-Dimethylphenylboronic Acid |
|||
abx188441-10g | Abbexa | 10 g | EUR 1045.2 |
6-Bromo-3-Pyridazinecarboxylic Acid |
|||
20-abx180652 | Abbexa |
|
|
(2-Bromomethylphenyl)Boronic Acid |
|||
20-abx180089 | Abbexa |
|
|
4-Bromo-2,5-difluorobenzeneboronic acid |
|||
20-abx183529 | Abbexa |
|
|
2-Bromomethyl-1-benzoic acid |
|||
abx183128-1g | Abbexa | 1 g | EUR 1429.2 |
2-Bromo-5-Chloro-Isonicotinic Acid |
|||
20-abx181728 | Abbexa |
|
|
4-Bromo-2-methyl-benzeneacetic acid |
|||
20-abx182053 | Abbexa |
|
|
2-(5-Bromo-2-Chlorophenyl)Acetic Acid |
|||
abx187878-250g | Abbexa | 250 g | EUR 1378.8 |
5-Bromopyridine-3-Boronic Acid |
|||
20-abx183704 | Abbexa |
|
|
6-Bromopyridine-3-Boronic Acid |
|||
20-abx183783 | Abbexa |
|
|
2-Bromopyridine-3-Boronic Acid |
|||
20-abx180304 | Abbexa |
|
|
4-Bromo-3-Methylthiophenecarboxylic Acid |
|||
20-abx186309 | Abbexa |
|
|
5-Bromoindole-2-Carboxylic Acid |
|||
20-abx188522 | Abbexa |
|
|
3-Pyridinecarboxylic acid, 2-bromo- |
|||
20-abx181128 | Abbexa |
|
|
2-Bromopyridin-4-Ylboronic Acid |
|||
20-abx180303 | Abbexa |
|
|
6-Bromo-1H-indole-2-carboxylic acid |
|||
20-abx183775 | Abbexa |
|
|
(3-Bromopyridin-4-Yl)Boronic Acid |
|||
20-abx180929 | Abbexa |
|
|
4-Bromo-1H-pyrrole-2-carboxylic acid |
|||
20-abx182047 | Abbexa |
|
|
3-Bromopyrazine-2-carboxylic acid |
|||
abx181923-1g | Abbexa | 1 g | EUR 678 |
4-Bromothiazole-2-carboxylic acid |
|||
20-abx182066 | Abbexa |
|
|
4-Bromopyridine-2-carboxylic acid |
|||
20-abx183552 | Abbexa |
|
|
2-Bromopyridine-4-carboxylic acid |
|||
20-abx185039 | Abbexa |
|
|
6-Bromo-1H-indazole-3-carboxylic acid |
|||
20-abx182267 | Abbexa |
|
|
4-Bromo-2-fluoro-5-methylbenzoic acid |
|||
20-abx183533 | Abbexa |
|
|
5-Bromo-1H-indazole-3-carboxylic acid |
|||
20-abx183670 | Abbexa |
|
|
3-Bromothiophene-2-carboxylic acid |
|||
20-abx181925 | Abbexa |
|
|
4-Bromothiophene-3-Carboxylic Acid |
|||
20-abx186067 | Abbexa |
|
|
2-Bromoethanesulfonic acid sodium salt |
|||
GK9684-25 | Glentham Life Sciences | 25 | EUR 67.9 |
5-Bromo-1-benzofuran-2-carboxylic acid |
|||
20-abx180048 | Abbexa |
|
|
2-(5-Bromopyridin-2-Yl)Acetic Acid |
|||
20-abx180208 | Abbexa |
|
|
3-Bromopropylboronic Acid, Pinacol Ester |
|||
abx188362-250g | Abbexa | 250 g | EUR 4068 |
5-Bromo-2-fluoropyridine-3-boronic acid |
|||
20-abx185953 | Abbexa |
|
|
5-Bromo-2-Methoxypyridine-3-Boronic Acid |
|||
20-abx185955 | Abbexa |
|
|
5-Bromo-4-Iodopyridine-3-Carboxylic Acid |
|||
abx186335-1g | Abbexa | 1 g | EUR 678 |
4-bromoisoquinoline-6-carboxylic acid |
|||
abx180515-1g | Abbexa | 1 g | EUR 2832 |
6-Bromo-2-Fluoro-3-Iodophenylboronic Acid |
|||
20-abx183777 | Abbexa |
|
|
5-Bromo-Pyridine-2,3-Dicarboxylic Acid |
|||
20-abx183703 | Abbexa |
|
|
5-Bromo-3-fluoro-2-pyridinecarboxylic acid |
|||
abx182195-1g | Abbexa | 1 g | EUR 360 |
4-Bromo-2-Methylpyrazole-3-Carboxylic Acid |
|||
abx188442-1g | Abbexa | 1 g | EUR 526.8 |
3-Bromo-6-chloro-2-pyridine carboxylic acid |
|||
20-abx185124 | Abbexa |
|
|
5-Bromo-2,3-Dihydrobenzofuran-7-Carboxylic Acid |
|||
abx188518-25g | Abbexa | 25 g | EUR 1612.8 |
3-Bromo-5-Fluoro-2-Methoxyphenylboronic Acid |
|||
20-abx185933 | Abbexa |
|
|
3-(3-Bromopropylcarbamoyl)Benzeneboronic Acid |
|||
20-abx188290 | Abbexa |
|
|
4-(3-Bromopropylcarbamoyl)Benzeneboronic Acid |
|||
20-abx188407 | Abbexa |
|
|
3-Bromo-2-fluoro--pyridine-5-carboxylic acid |
|||
abx185118-1g | Abbexa | 1 g | EUR 944.4 |
2-Pyridineacetic Acid, 5-Bromo-, Methyl Ester |
|||
20-abx181835 | Abbexa |
|
|
{3-[(2-Bromoethyl)Carbamoyl]Phenyl}Boronic Acid |
|||
20-abx188064 | Abbexa |
|
|
(2-Bromomethylphenyl)Boronic Acid, Pinacol Ester |
|||
20-abx184842 | Abbexa |
|
|
(1S)-(+)-3-Bromocamphor-10-sulfonic acid hydrate |
|||
GW5467-1 | Glentham Life Sciences | 1 | EUR 274.7 |
(1S)-(+)-3-Bromocamphor-10-sulfonic acid hydrate |
|||
GW5467-250 | Glentham Life Sciences | 250 | EUR 117.8 |
2-Bromo-4,5-Dimethoxy-Benzeneacetic Acid Methyl Ester |
|||
20-abx185033 | Abbexa |
|
|
6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)- |
|||
HY-21210 | MedChemExpress | 25mg | EUR 404.4 |
5-Bromopyridine-3-boronic acid,pinacol ester |
|||
20-abx182207 | Abbexa |
|
|
Boric Acid 1% w/v with Indi Bromo Green Methyl Red |
|||
BOAIG105 | Scientific Laboratory Supplies | 5L | EUR 140.4 |
6-Bromo-1-methyl-1H-indazole-3-carboxylic acid |
|||
abx182269-1g | Abbexa | 1 g | EUR 2532 |
4-(Bromomethyl)Benzeneboronic Acid Pinacol Ester, 95% |
|||
20-abx183468 | Abbexa |
|
|
NH2 of SAH through 6-bromocaproic acid (Digoxigenin) |
|||
20-abx083012 | Abbexa |
|
|
Carbamic Acid,(2-Bromoethoxy)-,1,1-Dimethylethyl Ester |
|||
abx188635-5g | Abbexa | 5 g | EUR 1713.6 |
5-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid |
|||
20-abx182205 | Abbexa |
|
|
7-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid |
|||
20-abx182334 | Abbexa |
|
|
6-Bromoimidazo[1,2-a]pyridine-2-carboxylic acid |
|||
20-abx184492 | Abbexa |
|
|
2-(4-Bromo-Phenyl)-Quinoline-4-Carboxylic Acid |
|||
20-abx186163 | Abbexa |
|
|
6-Bromoimidazo[1,2-a]pyridine-3-carboxylic acid |
|||
20-abx186720 | Abbexa |
|
|
6-Bromoimidazo[1,2-a]pyridine-8-carboxylic acid |
|||
20-abx186738 | Abbexa |
|
|
5-Bromo-2-Methoxypyridine-3-Boronic Acid Pinacol Ester |
|||
20-abx185956 | Abbexa |
|
|
5-Bromo-3-chloro-2-pyridinecarboxylic acid methyl ester |
|||
20-abx183695 | Abbexa |
|
|
(6-Bromo-Isochroman-1-Yl)-Acetic Acid Ethyl Ester |
|||
20-abx184860 | Abbexa |
|
|
2-Bromomethylphenylboronic acid,neopentyl glycol ester |
|||
20-abx185626 | Abbexa |
|
|
2-Bromomethyl-4-methyl-benzoic acid methyl ester |
|||
20-abx181740 | Abbexa |
|
|
Bromo-2,3,4-tri-O-benzoyl-α-D-glucuronic acid methyl ester |
|||
GC8096-1 | Glentham Life Sciences | 1 | EUR 522 |
Bromo-2,3,4-tri-O-benzoyl-α-D-glucuronic acid methyl ester |
|||
GC8096-2 | Glentham Life Sciences | 2 | EUR 857.7 |
Bromo-2,3,4-tri-O-benzoyl-α-D-glucuronic acid methyl ester |
|||
GC8096-5 | Glentham Life Sciences | 5 | EUR 1845.7 |
Bromo-2,3,4-tri-O-benzoyl-α-D-glucuronic acid methyl ester |
|||
GC8096-500 | Glentham Life Sciences | 500 | EUR 344.8 |
1,2-Benzenedicarboxylic Acid,3-Bromo-,1,2-Dimethyl Ester |
|||
20-abx182829 | Abbexa |
|
|
6-Bromo-Pyrazolo[1,5-A]Pyrimidine-2-Carboxylic Acid |
|||
20-abx180654 | Abbexa |
|
|
(5-Bromopyridin-2-ylmethyl)carbamic acid tert-butyl ester |
|||
20-abx180103 | Abbexa |
|
|
1H-Indole-4-carboxylic acid, 6-broMo-3-Methyl-1-(1-Methylpropyl)- |
|||
20-abx184940 | Abbexa |
|
|